Heller G.T., Aprile F.A., Michaels T.C.T., Limbocker R., Perni M., Ruggeri F.S., Mannini B., Löhr T., Bonomi M., Camilloni C., De Simone A., Felli I.C., Pierattelli R., Knowles T.P.J., Dobson C.M., and Vendruscolo M. (2020) Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease. SCI. ADV. 6: eabb5924 [bioRxiv]
Karlsson E., Paissoni C., Erkelens A.M., Tehranizadeh Z.A., Sorgenfrei F.A., Andersson E., Ye W., Camilloni C., and Jemth P. (2020) Mapping the transition state for a binding reaction between ancient intrinsically disordered proteins. J. BIOL. CHEM. 295: 17698-17712 [bioRxiv]
Nardone V., Chaves-Sanjuan A., Lapi M., Airoldi C., Saponaro A., Pasqualato S., Dolfini D., Camilloni C., Bernardini A., Gnesutta N., Mantovani R., and Nardini M. (2020) Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin. CELLS 9: 2370 [PDB: 7AH8]
Jussupow A., Messias A.C., Stehle R., Geerlof A., Solbak S.M.Ø., Paissoni C., Bach A., Sattler M., and Camilloni C. (2020) The dynamics of linear polyubiquitin. SCI. ADV. 6: eabc3786 [bioRxiv] 
Sala B.M., Le Marchand T., Pintacuda G., Camilloni C., Natalello A., and Ricagno S. (2020) Conformational stability and dynamics in crystals recapitulate protein behaviour in solution. BIOPHYS. J. 119: 978-988 [bioRxiv]
Paissoni C., Jussupow A., and Camilloni C. (2020) Determination of Protein Structural Ensembles by Hybrid-Resolution SAXS Restrained Molecular Dynamics. J. CHEM. THEORY COMPUT. 16: 2825-2834 [ChemRxiv]
Niu Z., Prade E., Malideli E., Hille K., Jussupow A., Mideksa Y.G., Yan L., Qian C., Fleisch M., Messias A.C, Sarkar R., Sattler M., Lamb D.C, Feige M.J, Camilloni C., Kapurniotu A., and Reif B. (2020) Structural insight into IAPP-derived amyloid inhibitors and their mechanism of action. ANGEW. CHEM. 59: 5771-5781
Achour A., Broggini L., Han X., Sun R., Santambrogio C., Buratto J., Visentin C., Barbiroli A., De Luca C.M.G., Sormanni P., Moda F., De Simone A., Sandalova T., Grandori R., Camilloni C., and Ricagno S. (2020) Biochemical and biophysical comparison of human and mouse beta‐2 microglobulin reveals the molecular determinants of low amyloid propensity. FEBS J. 287: 546-560 
[PDB: 6I8C]